Sprint Bioscience, Max IV Receive Funding From Vinnova
Sprint Bioscience AB has received funding from Vinnova, along with partner Max IV.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.